Yahooยท48 event signal
Eli Lilly Says Taltz/Zepbound Combo Shows Long-Term Efficacy in Psoriatic Arthritis Trial
businessLLY
Eli Lilly and Co. (NYSE:LLY) on Wednesday presented new clinical data showing the lasting benefits of a dual-drug approach for active psoriatic arthritis.Detailed 52-week results indicate sustained and...
Put this headline into context
Use TradingAgents AI to connect the story to the company's filings, fundamentals, market structure, competing bull and bear arguments, and risk review.
Source: FreeNewsAPIRead at Yahoo
Headlines and excerpts belong to the original publisher. Ticker associations are informational and may be incomplete. Market news is not personalized financial advice.